Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Commercial
Merger
Merger
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merger
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ
Biospace News
-
February 26, 2021
Merger
Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio
Merger
Chinook Applies Precision Medicine to Kidney Therapeutics for Rapid Advances
Merger
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
Merger
ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company
Merger
Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021...
Biospace News
-
December 22, 2020
0
Merger
Leading BioSciences and Seneca Biopharma Announce Merger
-
December 18, 2020
0
Merger
Lilly Announces Agreement to Acquire Prevail Therapeutics
-
December 16, 2020
0
Merger
AstraZeneca to acquire Alexion, accelerating the Company’s strategic and financial development
-
December 12, 2020
0
Merger
Gilead Sciences to Acquire MYR GmbH
-
December 10, 2020
0
1
2
3
...
9
Page 1 of 9
- Advertisement -
MOST POPULAR
Sol-Gel’s acne vulgaris treatment Twyneo achieves main goals in Phase III...
December 30, 2019
Deepening Its Immune-Related Disease Pipeline, Alexion Buys Achillion for $930 Million
October 16, 2019
Recent Financing Rounds in the Biopharma Industry
November 12, 2019
Dystrogen Therapeutics Announces That Gene Therapy Successfully Cuts Off Production of...
April 5, 2019
Load more
HOT NEWS
Clinical
Synedgen Receives Supplemental NEI Funding to Identify Lead Development Candidate for...
Clinical
BMS, bluebird Publish Ide-Cel Data in NEJM, One Month Ahead of...
Commercial
GT Biopharma (GTBP) to Broadcast Update on TriKE Initiatives for HIV...
Others
Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and...
